Observational study finds more pathologic nodal upstaging with more nodes sampled ...

Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node ...

LOS ANGELES -- Surgeries to remove small tumors in stage IA non-small cell lung cancer (NSCLC) were associated with varying odds of long-term survival depending on the amount of lung removed, based on ...

Patients who underwent video-assisted thoracoscopic surgery (VATS) compared to open lobectomy had a significantly improved overall survival rate, according to a meta-analysis presented at the ...

When appropriate, surgery remains the most effective treatment option for non-small cell lung cancer (NSCLC), including for patients with COPD, said Friedberg, professor in the Department of Thoracic ...

Dr. Benny Weksler is helping patients breathe a little easier. As system chief of thoracic surgery at Allegheny Health Network, the Edgeworth resident leads the lung cancer lobectomy surgery program, ...

Combining patient- and clinician-facing support tools could significantly improve identification of individuals eligible for ...

Background: Chest drains are routinely used after video-assisted thoracoscopic surgery (VATS) lung resections to evacuate fluid and air from the pleural space. We compared the impact of coaxial ...

Stage 1 lung carcinoid tumors are confined to the lung and have not spread to lymph nodes or distant organs. Tumors at this stage are typically small and localized, which often allows for curative ...

Alecensa achieved a 4-year OS rate of 98.4% in resected ALK-positive early-stage NSCLC, outperforming chemotherapy. The ALINA study showed a 65% reduction in disease recurrence or death risk with ...